The Almac Pod™ – Changing the Dynamics of Temperature Controlled Shipping Solutions
May 9, 2016
Craigavon, N.I., UK, 9 May 2016 – With the rise of biologics and the introduction of strict Good Distribution Practices (GDP), Almac has recognised the need for a change in dynamics of temperature controlled shipping, with the launch of their new Almac Pod™ service solution.
Understanding the cost, logistical, and compliance challenges posed by this changing environment, the Almac Pod™ is a first-to-market service solution that incorporates the efficiencies of the Almac-approved, global courier network and advanced phase change technology (PCM) to create a temperature-controlled shipping service solution that eases the burden for their global clinical supply customers.
The Almac Pod™ offers a Protected, Optimised and Dynamic solution that safeguards customers’ products and mitigates against temperature excursions of all clinical shipments– the perfect solution for Biologics or difficult to handle products. Since launching the service, the Almac Pod™ has been 100% effective in protecting the integrity of shipped products with no known temperature excursions within the shipper qualification period.
Andrew Scott, Head of Logistics (EU) commented:
“I am delighted to announce the success of our new temperature-controlled shipping service solution – the Almac Pod™. With rapid growth in the volume of our controlled temperature shipments over the past few years, the introduction of innovative solutions such as the Almac Pod™ allows us to deliver on the growing needs of our clinical trial supply customers. The service has enabled us to achieve a major step up in protection for temperature controlled products during transit that competes head to head with the traditional water based solutions. The Almac Pod™ is fully GDP-compliant and is available as part of Almac’s end-to-end, global supply chain management solution – your product, safe in our hands.”
For further details on the Almac Pod™, download the whitepaper: Changing the Dynamics of Temperature Controlled Shipping solutions here.
About Almac Group
‘Partnering to Advance Human Health’
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to over 600 companies globally within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).